Form 4: Precision BioSciences Director Wadsworth Reports Stock Vesting
SEC Form 4 Filing
Director Samuel C. Wadsworth reports the vesting and settlement of 4,202 Restricted Stock Units into common stock of Precision BioSciences.
Summary
- On May 4, 2024, Samuel C. Wadsworth, a director of Precision BioSciences, Inc., had 4,202 Restricted Stock Units (RSUs) vest and settle into common stock.
- Each RSU represents a contingent right to receive one share of the Issuer's Common Stock.
- The RSUs were granted on May 4, 2023, and vested in full on May 4, 2024.
- The reported amounts of securities have been adjusted to reflect a 1-for-30 reverse stock split that occurred on February 13, 2024.
Sentiment
Score: 5
Explanation: This is a neutral event, reflecting scheduled vesting of stock options. It doesn't inherently indicate positive or negative sentiment.
Industry Context
This filing is a routine disclosure of insider transactions, which are common in publicly traded companies. It provides transparency into the holdings and transactions of company insiders.
Stakeholder Impact
- The vesting of RSUs increases the number of shares outstanding, which could have a minor dilutive effect on existing shareholders.
Key Dates
| Date | Description |
|---|---|
| 05/04/2023 | Reporting Person was granted RSUs |
| 02/13/2024 | Issuer effected a 1-for-30 reverse stock split |
| 05/04/2024 | RSUs vested in full |
| 05/04/2024 | Vesting and settlement of Restricted Stock Units (RSUs) |
| 05/07/2024 | Date of report |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.